Cargando…

An Integrated Population Pharmacokinetic Meta-Analysis of Propofol in Morbidly Obese and Nonobese Adults, Adolescents, and Children

This study describes a population pharmacokinetic meta-analysis of propofol to characterize the influence of body size measures and age in morbidly obese and nonobese adults, adolescents, and children. Sixty morbidly obese and nonobese adult patients (55–167 kg; 21–79 years) and 34 morbidly obese an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diepstraten, J, Chidambaran, V, Sadhasivam, S, Blussé van Oud-Alblas, H J, Inge, T, van Ramshorst, B, van Dongen, E P A, Vinks, A A, Knibbe, C A J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026632/ https://www.ncbi.nlm.nih.gov/pubmed/24026252 http://dx.doi.org/10.1038/psp.2013.47

Ejemplares similares

Evaluation of propofol anesthesia in morbidly obese children and adolescents
por: Chidambaran, Vidya, et al.
Publicado: (2013)

Population pharmacokinetic-pharmacodynamic model of propofol in adolescents undergoing scoliosis surgery with intraoperative wake-up test: a study using Bispectral index and composite auditory evoked potentials as pharmacodynamic endpoints
por: Blussé van Oud-Alblas, Heleen J., et al.
Publicado: (2019)

Propofol and thiopental for refractory status epilepticus in children
por: van Gestel, S, et al.
Publicado: (2005)

Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide
por: de Hoogd, Sjoerd, et al.
Publicado: (2017)

The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery
por: Brill, Margreke J., et al.
Publicado: (2015)

Midazolam Pharmacokinetics in Morbidly Obese Patients Following Semi-Simultaneous Oral and Intravenous Administration: A Comparison with Healthy Volunteers
por: Brill, Margreke J. E., et al.
Publicado: (2014)

Semiphysiologically based pharmacokinetic model for midazolam and CYP3A mediated metabolite 1‐OH‐midazolam in morbidly obese and weight loss surgery patients
por: Brill, MJE, et al.
Publicado: (2015)

Higher Midazolam Clearance in Obese Adolescents Compared with Morbidly Obese Adults
por: van Rongen, Anne, et al.
Publicado: (2017)

Propofol Pharmacokinetics and Estimation of Fetal Propofol Exposure during Mid-Gestational Fetal Surgery: A Maternal-Fetal Sheep Model
por: Ngamprasertwong, Pornswan, et al.
Publicado: (2016)

Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals
por: Smit, Cornelis, et al.
Publicado: (2020)

A Bodyweight-Dependent Allometric Exponent for Scaling Clearance Across the Human Life-Span
por: Wang, Chenguang, et al.
Publicado: (2012)

Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen
por: van Rongen, Anne, et al.
Publicado: (2016)

Ciprofloxacin Pharmacokinetics After Oral and Intravenous Administration in (Morbidly) Obese and Non-obese Individuals: A Prospective Clinical Study
por: van Rhee, Koen P., et al.
Publicado: (2022)

Oral drug dosing following bariatric surgery: General concepts and specific dosing advice
por: Kingma, Jurjen S., et al.
Publicado: (2021)

ABCC3 Genetic Variants are Associated with Postoperative Morphine-induced Respiratory Depression and Morphine Pharmacokinetics in Children
por: Chidambaran, Vidya, et al.
Publicado: (2016)

Does Weight Impact Anidulafungin Pharmacokinetics?
por: Lempers, Vincent J., et al.
Publicado: (2016)

A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients
por: Smit, Cornelis, et al.
Publicado: (2019)

Preoperative frailty and chronic pain after cardiac surgery: a prospective observational study
por: Arends, Britta C., et al.
Publicado: (2022)

Elective adhesiolysis for chronic abdominal pain reduces long-term risk of adhesive small bowel obstruction
por: van den Beukel, Barend A. W., et al.
Publicado: (2023)

Pharmacokinetics of Orally Administered Oseltamivir in Healthy Obese and Nonobese Thai Subjects
por: Jittamala, Podjanee, et al.
Publicado: (2014)

Salivary Cortisol and Binge Eating Disorder in Obese Women After Surgery for Morbid Obesity
por: Larsen, Junilla K., et al.
Publicado: (2009)

Video consultation during follow up care: effect on quality of care and patient- and provider attitude in patients with colorectal cancer
por: Barsom, Esther Z., et al.
Publicado: (2020)

Comparing performance of McGrath MAC videolaryngoscope in morbidly obese and nonobese patients
por: GAO, Ying, et al.
Publicado: (2020)

In reply: Comparing performance of McGrath MAC videolaryngoscope in morbidly obese and nonobese
por: ARSLAN, Zehra İpek
Publicado: (2020)

Fixed Dosing of Liposomal Amphotericin B in Morbidly Obese Individuals
por: Wasmann, Roeland E, et al.
Publicado: (2020)

Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Non-obese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study
por: Smit, Cornelis, et al.
Publicado: (2019)

Inflammatory T-lymphocyte proliferation in morbid obesity
por: Van der Weerd, K, et al.
Publicado: (2010)

Propofol pharmacokinetics in preterm and term neonates: the relevance of both postmenstrual and postnatal age
por: Allegaert, K, et al.
Publicado: (2008)

Tracheal intubation with the McGrath MAC X-blade videolaryngoscope in morbidly obese and nonobese patients
por: ARSLAN, Zehra Ipek, et al.
Publicado: (2019)

Increased Metformin Clearance in Overweight and Obese Adolescents: A Pharmacokinetic Substudy of a Randomized Controlled Trial
por: van Rongen, Anne, et al.
Publicado: (2018)

Is There a Difference in PROMs Between Morbidly Obese Patients and Nonobese Patients Following Primary Total Knee Arthroplasty?
por: Abhari, Sarag, et al.
Publicado: (2023)

C-reactive protein haplotypes and dispositional optimism in obese and nonobese elderly subjects
por: Rius-Ottenheim, Nathaly, et al.
Publicado: (2011)

The Future of Physiologically Based Pharmacokinetic Modeling to Predict Drug Exposure in Pregnant Women
por: Vinks, A A
Publicado: (2013)

Ventricular Dysfunction in Obese and Nonobese Rats with Metabolic Syndrome
por: Torres-Jacome, Julian, et al.
Publicado: (2022)

Role of Oxidative Stress in Obese and Nonobese PCOS Patients
por: Uçkan, Kazım, et al.
Publicado: (2022)

Metabolomic Profiles of Nonobese and Obese Women With Gestational Diabetes
por: Sormunen-Harju, Heidi, et al.
Publicado: (2023)

Increased Arterial Stiffness in Adolescents With Obesity
por: Lentferink, Yvette E., et al.
Publicado: (2019)

Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics
por: Busse, David, et al.
Publicado: (2021)

High Blood Pressure in Obese and Nonobese Japanese Children: Blood Pressure Measurement is Necessary Even in Nonobese Japanese Children
por: Shirasawa, Takako, et al.
Publicado: (2010)

Dose recommendations for gentamicin in the real-world obese population with varying body weight and renal (dys)function
por: Smit, Cornelis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_33ucndr9faomn8v97o4trdbtnq